Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Neoadjuvant Chemotherapy Regimen Choice in Breast Cancer

NCT01732939 is registered in ClinicalTrials.gov with Hospital Affiliated to Military Medical Science, Beijing as lead sponsor.

NCT NCT01732939
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01732939 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Neoadjuvant Chemotherapy Regimen Choice in Breast Cancer
Lead sponsor
Hospital Affiliated to Military Medical Science, Beijing
Phase
Observational
Overall status
Unknown status
Start date
May 31, 2012
Completion date
May 31, 2014
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer